Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1746 | 0.93 | — | — | |
| SCHEMBL5544690 | 0.93 | MEN1 (0.42) | MEN1KMT2A | |
| SCHEMBL7097725 | 0.93 | — | — | |
| N,N-Dimethylethanaminium SCHEMBL854736 | 0.90 | MEN1 (0.36) | MEN1KMT2A | |
| SCHEMBL2232066 | 0.89 | MEN1 (0.40) | MEN1KMT2A | |
| SCHEMBL3210291 | 0.89 | MEN1 (0.40) | MEN1KMT2A | |
| Fluoride SCHEMBL73855 | 0.89 | MEN1 (0.40) | MEN1KMT2A | |
| SCHEMBL319537 | 0.89 | MEN1 (0.40) | MEN1KMT2A | |
| Hydrochloric Acid SCHEMBL22577541 | 0.89 | MEN1 (0.40) | MEN1KMT2A | |
| Ammonia Solution, Strong SCHEMBL1997314 | 0.89 | MEN1 (0.40) | MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230390322-A1 | HIGH CONCENTRATION METHYLCOBALAMIN OR COMBINATION OF METHYL- AND HYDROXY-COBALAMIN FOR THE TREATMENT OF COBALAMIN C DEFICIENCY DISORDERS | THE U.S.A., AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2023-12-07 | — | — | US | disclosed |
| WO-2022081601-A1 | HIGH CONCENTRATION METHYLCOBALAMIN OR COMBINATION OF METHYL- AND HYDROXY-COBALAMIN FOR THE TREATMENT OF COBALAMIN C DEFICIENCY DISORDERS | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2022-04-21 | — | — | WO | disclosed |
| WO-2018046684-A1 | PROCESS FOR THE PREPARATION OF SUBSTITUTED 5-{[2-(ALKOXYMETHYL)-3,3,3-TRIFLUORO-2-HYDROXY-1-PHENYLPROPYL]AMINO}QUINOLIN-2(1H)-ONES | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2018-03-15 | — | — | WO | disclosed |
| CN-102475891-A | PH-responsive polyethylene glycol-anticarcinogen conjugate, and synthetic method and application thereof | CHINESE ACAD INST CHEMISTRY | 2012-05-30 | — | — | CN | disclosed |
| US-20080039422-A1 | Vitamin B12-Containing Compositions and Methods of Use | TRANSITION THERAPEUTICS INC. (CA) | 2008-02-14 | — | — | US | disclosed |
| WO-2003045969-A1 | COUPLING REAGENT FOR H-PHOSPHONATE CHEMISTRY | AVECIA BIOTECHNOLOGY INC. (US) | 2003-06-05 | — | — | WO | disclosed |
| EP-0624163-B1 | CYCLIC CALCITONIN DERIVATIVES AND METHOD FOR THEIR PRODUCTION | SMITHKLINE BEECHAM FARMA (IT) | 1998-03-25 | — | — | EP | disclosed |
| EP-0624163-A1 | CYCLIC CALCITONIN DERIVATIVES AND METHOD FOR THEIR PRODUCTION | Smithkline Beecham Farmaceutici S.p.A. (IT) | 1994-11-17 | — | — | EP | disclosed |
| WO-1993015106-A1 | CYCLIC CALCITONINE DERIVATIVES AND METHOD FOR THEIR PRODUCTION | SMITHKLINE BEECHAM FARMACEUTICI S.P.A. (IT) | 1993-08-05 | — | — | WO | disclosed |